ArticleBMC genomics2022

Combined PD-1/PD-L1 and tumor-infiltrating immune cells redefined a unique molecular subtype of high-grade serous ovarian carcinoma.

Ping Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.